Longrong Wang
- Topics
- RNA modifications and cancer (7 papers)Hepatocellular Carcinoma Treatment and Prognosis (5 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers)
- Partner nations
- ChinaIsraelNetherlands
In The Last Decade
Longrong Wang
26 papers receiving 555 citations
Peers
Comparison fields: 5 of 66
- Molecular Biology 327
- Cancer Research 248
- Oncology 114
- Pulmonary and Respiratory Medicine 112
- Surgery 104
Countries citing papers authored by Longrong Wang
This map shows the geographic impact of Longrong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Longrong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Longrong Wang more than expected).
Fields of papers citing papers by Longrong Wang
This network shows the impact of papers produced by Longrong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Longrong Wang. The network helps show where Longrong Wang may publish in the future.
Co-authorship network of co-authors of Longrong Wang
This figure shows the co-authorship network connecting the top 25 collaborators of Longrong Wang. A scholar is included among the top collaborators of Longrong Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Longrong Wang. Longrong Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 84 | |
| 3 | 4 | |
| 4 | 4 | |
| 5 | 3 | |
| 6 | 9 | |
| 7 | 38 | |
| 8 | 8 | |
| 9 | 8 | |
| 10 | 5 | |
| 11 | 25 | |
| 12 | 36 | |
| 13 | 11 | |
| 14 | 10 | |
| 15 | 13 | |
| 16 | 19 | |
| 17 | 16 | |
| 18 | 6 | |
| 19 | 43 | |
| 20 | 102 |
About Longrong Wang
Longrong Wang is a scholar working on Cancer Research, Hepatology and Oncology, having authored 26 papers that have together received 560 indexed citations. Recurring topics across this work include RNA modifications and cancer (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). The work is most often cited by research in Cancer Research (248 citations), Hepatology (53 citations) and Molecular Biology (327 citations). Longrong Wang has collaborated with scholars based in China, Israel and Netherlands. Frequent co-authors include Jiamin Zhou, Yiming Zhao, Anrong Mao, Miao Wang, Xigan He, Weiping Zhu, Ti Zhang, Qi Pan, Yun Feng and Miao Wang. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.